Dynamic Management of Lung Cancer Care During Surging COVID-19Surgery Published on 2021-04-072022-10-31 Journal: Frontiers in Surgery [Category] COVID-19, [키워드] adopted Care Complication COVID-19 COVID-19 pandemic dynamic healthcare help increased risk lung cancer lung cancer patient lung cancer patients management New York New York City outcome Patient patients Radiation Oncology recommendation Screening subset surgical Thoracic Surgery Transmission university [DOI] 10.3389/fsurg.2021.663364 PMC 바로가기 [Article Type] Surgery
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies재활용된 COVID-19 약물과 폐암 약물 요법의 잠재적 약물 상호 작용Review Published on 2021-04-012022-08-31 Journal: Archives of medical research [Category] MERS, SARS, 신약개발, 치료제, [키워드] adverse outcomes anti-cancer treatment Azithromycin cancer patient Care ceftriaxone Chemotherapy Chloroquine Comorbidity Complication concomitant treatment concomitant treatments COVID-19 COVID-19 infection COVID-19 pandemic Dexamethasone dissemination drug Drug interactions drug-drug interaction Drug-drug interactions Famotidine Favipiravir Healthcare professional healthcare professionals history of smoking Hydroxychloroquine identification identify Immunosuppression information kinase inhibitors Lopinavir Lopinavir/ritonavir lung cancer lung cancer patient lung cancer patients malignancy management medication medications occur oseltamivir outcome Patient pharmacotherapy Potential Prophylactic proportion QT prolongation rationale receiving recent Remdesivir reported Reporting Repurposed drug ribavirin risk risk factor Ritonavir sarilumab severity smoking Tocilizumab tyrosine tyrosine kinase inhibitors umifenovir with COVID-19 [DOI] 10.1016/j.arcmed.2020.11.006 PMC 바로가기 [Article Type] Review
Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma PatientsArticle Published on 2021-03-122022-10-31 Journal: Cancers [Category] COVID-19, [키워드] ACE2 ACE2 expression acute respiratory syndrome adenocarcinoma alveolar alveolar epithelial cells Analysis AT2 Cancer CD36 Cell cells cellular distribution Clinical management co-expressed Cohort coronavirus coronavirus disease COVID-19 COVID-19 pandemic death rates Defense DMBT1 elevated enzyme epithelial cell examined Express expressed expression expression level expression profile Features Genes Health HHIP highest Host host protein identify implicated individual Inflammation landscape lung lung adenocarcinoma lung cancer patient lung cancer patients lung cell lung cells lung epithelial Lung epithelial cells Lung inflammation lung neoplasms malignant marker Mortality normal novel coronavirus SARS-CoV-2 offer pandemic pathway patients patients with comorbidity Pneumonia Population positively correlated Potential treatment presenting Proteases proteases Tmprss2 pulmonary raising receptor Respiratory complications Respiratory failure risk SARS-CoV-2 SARS-CoV-2 entry SARS-CoV-2 receptor scRNA-seq significantly simple single-cell Single-cell RNA sequencing Single-cell RNA-sequencing Spread symptomatic target the United State therapeutic target tissue TMPRSS2 TMPRSS4 [DOI] 10.3390/cancers13061250 PMC 바로가기 [Article Type] Article
Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants코로나19 환자에 대한 암의 영향: 63,019명의 참가자에 대한 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-02-152022-09-10 Journal: Cancer Biology & Medicine [Category] MERS, 치료기술, [키워드] 95% CI 95% confidence interval Cancer cancer patient Cancer patients CIs Clinical management clinician conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients determine diagnosed with COVID-19 Effect heterogeneity incidence increased mortality information lung cancer lung cancer patient lung cancer patients medRxiv meta-analyses Meta-analysis Mortality mortality rate participant Patient Patients with cancer patients with COVID-19 provided random-effects model Retrospective study risk factor risk ratio risk ratios RRs specific type specific types suggested susceptible systematic review those without cancer underlying disease underlying diseases Web of Science were used with COVID-19 [DOI] 10.20892/j.issn.2095-3941.2020.0559 PMC 바로가기 [Article Type] Meta-Analysis
Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genesResearch Paper Published on 2021-02-092022-10-04 Journal: Current Research in Microbial Sciences [Category] 바이오마커, 변종, [키워드] ACE2 amino acid sequence Analysis approach binding activity Biomarker cancer patient caused Cell co-expressed Comorbidity COVID-19 COVID-19 infection CXCL10 cytokine Cytokine storm database disease entry of SARS-CoV-2 enzyme evaluate expression fatality Frequency functional Genetic host cell hub protein immune response involved lung lung adenocarcinoma lung cancer lung cancer patient lung cancer patients lung cell motif Mutation overexpressed pandemic disease PPI network protein sequences receptor protein reported respiratory responsible SARS- CoV-2 SARS-CoV-2 susceptibility susceptible upregulated [DOI] 10.1016/j.crmicr.2021.100022 PMC 바로가기 [Article Type] Research Paper
Prolonged SARS-CoV-2-RNA Detection from Nasopharyngeal Swabs in an Oncologic Patient: What Impact on Cancer Treatment?종양 환자의 비인두 면봉에서 장기간 SARS-CoV-2-RNA 검출: 암 치료에 어떤 영향을 미칩니까?Case Reports Published on 2021-02-082022-09-11 Journal: Current Oncology [Category] MERS, 치료기술, [키워드] absence affecting association Cancer cancer patient Cancer patients cancer treatment Cell clinical symptom Clinical symptoms complications COVID-19 Culture detection diagnosis of SARS-CoV-2 diagnostic exhibited Impact Infection Isolation lung cancer lung cancer patient lung cancer patients management measure nasopharyngeal Nasopharyngeal swab nasopharyngeal swabs Non-small cell lung cancer overlap pandemic Patient PCR assays Prolonged Radiotherapy remains uncertain risk RT-PCR assay RT-PCR assays SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA SARS-CoV-2 viral symptoms of infection the patient Trachea Viral viral culture [DOI] 10.3390/curroncol28010083 PMC 바로가기 [Article Type] Case Reports
Is COVID-19 a high risk factor for lung cancer? A protocol for systematic review and meta-analysisCOVID-19는 폐암의 고위험 인자입니까? 체계적인 검토 및 메타 분석을 위한 프로토콜5700 Published on 2021-01-082022-08-31 Journal: Medicine [Category] COVID-19, meta-analysis, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis approval asymptomatic patient bias risk caused Clinical outcome Clinical treatment Complication coronavirus COVID-19 database death develop eligible Ethics evaluate evaluated Evidence Guidance Health healthy individual healthy individuals heterogeneity high risk identify incidence infected with COVID-19 infected with SARS-CoV-2 International lung lung cancer lung cancer patient lung cancer patients Meta-analysis Patient peer-reviewed performed postoperative present Prevalence Prognosis protocol receive reported required research finding respiratory Risk assessment risk factor SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe pneumonia Severity rate Stata statistically Support surgical surgical treatment systematic review Treatment worse prognosis [DOI] 10.1097/MD.0000000000023877 PMC 바로가기 [Article Type] 5700
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?Review Published on 2020-12-222022-10-29 Journal: International Journal of Molecular Sciences [Category] B형 간염, COVID-19, MERS, [키워드] administration affecting Analysis Antibiotic therapy anticancer Antiretroviral therapy Bacterial infections Cancer cancer patient Clinical practice clinical trial complex correlation COVID-19 described disease Evidence excluded HBV HCV Hepatitis HIV Immune checkpoint inhibitors immune system Immunotherapy impairing implication Infection Infectious disease lung cancer lung cancer patient lung cancer patients management microbiota Mortality Non-small cell lung cancer outcome Patient patient subgroup patients patients treated performed Prognosis prognostic Prospective trial reported retrospective risk of COVID-19 safety profile suggested therapy Thoracic toxicities Treatment trials viral infection viral infections virus with HIV [DOI] 10.3390/ijms22010042 PMC 바로가기 [Article Type] Review
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses컴퓨터 분석을 사용한 SARS-CoV-2 감염 관련 폐암의 잠재적 바이오마커로서의 ACE2 단백질 식별Article Published on 2020-11-012022-09-11 Journal: Genomics [Category] 바이오마커, 변종, 유전자 메커니즘, [키워드] ACE2 ACE2 expression ACE2 receptor age Analysis analyzed angiotensin-converting enzyme 2 Atla best Biomarker Biomarkers cancer patient caused Clinical characteristics co-expressed COVID-19 COVID-19 disease eight expression Factor functional Functional assessment Gender Genes Host identification interactions investigated knowledge lack lung lung adenocarcinoma lung cancer lung cancer patient lung cancer patients mechanism miRNAs mRNA expression mRNA expression analysis. pandemic performed positive Potential Potential biomarker Prognosis Protein relationship Relationship of lung cancer and COVID-19 SARS-CoV-2 SARS-COV-2 infection signaling pathway Spread survival rate susceptible TFS therapy transcription factors up-regulation was performed [DOI] 10.1016/j.ygeno.2020.09.002 PMC 바로가기 [Article Type] Article
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in MadridOncology Published on 2020-09-162022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] abnormality acute respiratory distress Admission affected Anti-viral treatment anticoagulation ARDS baseline cancer patient cancer treatment conditions coronavirus Corticosteroids cough COVID-19 COVID-19 illness D-dimer diagnosed with COVID-19 Diagnosis discharged elevated Fever fibrinogen first positive high mortality rate high variability hospital Hospitalization hospitalized patient Hydroxychloroquine Immunotherapy incidence inflammation marker Inflammatory invasive lab lung cancer lung cancer patient lung cancer patients lymphocyte measure Mortality Multiple multivariate multivariate model neutrophil no difference outcome pandemic Patient patients PCR Pneumonia PROTECT Protein receiving risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 RT-PCR Shortness of breath Spain statistically significant symptoms onset syndrome targeted therapy Tertiary therapy Thoracic time Tocilizumab Treatment variable [DOI] 10.3389/fonc.2020.01777 PMC 바로가기 [Article Type] Oncology